Patents by Inventor David (Jong-Han) Park

David (Jong-Han) Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130196955
    Abstract: The invention provides compositions and methods for determining the increased risk for recurrence of certain cancers and the likelihood of successful treatment with one or both of chemotherapy and radiation therapy. The methods comprising determining the type of genomic polymorphism present in a predetermined region of the gene of interest isolated from the subject or patient. Also provided are nucleic acid probes and kits for determining a patient's cancer risk and treatment response.
    Type: Application
    Filed: February 1, 2013
    Publication date: August 1, 2013
    Inventors: Heinz-Josef Lenz, Jan Stoehlmacher, David Jong-Han Park
  • Publication number: 20120122946
    Abstract: The invention provides compositions and methods for determining the increased risk for recurrence of certain cancers and the likelihood of successful treatment with one or both of chemotherapy and radiation therapy. The methods comprising determining the type of genomic polymorphism present in a predetermined region of the gene of interest isolated from the subject or patient. Also provided are nucleic acid probes and kits for determining a patient's cancer risk and treatment response.
    Type: Application
    Filed: October 17, 2011
    Publication date: May 17, 2012
    Inventors: Heinz-Josef LENZ, Jan Stoehlmacher, David (Jong-Han) Park
  • Publication number: 20100173922
    Abstract: The invention provides compositions and methods for determining the increased risk for recurrence of certain cancers and the likelihood of successful treatment with one or both of chemotherapy and radiation therapy. The methods comprising determining the type of genomic polymorphism present in a predetermined region of the gene of interest isolated from the subject or patient. Also provided are nucleic acid probes and kits for determining a patient's cancer risk and treatment response.
    Type: Application
    Filed: December 30, 2009
    Publication date: July 8, 2010
    Inventors: Heinz-Josef Lenz, Jan Stoehlmacher, David (Jong-Han) Park
  • Patent number: 7662553
    Abstract: The invention provides compositions and methods for determining the increased risks for recurrence of certain cancers and the likelihood of successful treatment with one or both of chemotherapy and radiation therapy. The methods comprising determining the type of genomic polymorphism present in a predetermined region of the gene of interest isolated from the subject or patient. Also provided are nucleic acid probes and kits for determining a patient's cancer risk and treatment response.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: February 16, 2010
    Assignee: University of Southern California
    Inventors: Heinz-Josef Lenz, Jan Stoehlmacher, David (Jong-Han) Park
  • Publication number: 20060094012
    Abstract: The invention provides compositions and methods for determining the increased risks for recurrence of certain cancers and the likelihood of successful treatment with one or both of chemotherapy and radiation therapy. The methods comprising determining the type of genomic polymorphism present in a predetermined region of the gene of interest isolated from the subject or patient. Also provided are nucleic acid probes and kits for determining a patient's cancer risk and treatment response.
    Type: Application
    Filed: July 31, 2003
    Publication date: May 4, 2006
    Applicant: University of Southern California
    Inventors: Heinz-Josef Lenz, Jan Stoehlmacher, David (Jong-Han) Park